Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY-NCThe Cochrane database of systematic reviews

Smoking cessation interventions in adults with attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).

  • Sarah Milne1
  • Nicola Blake1
  • Emma Jones2
  • Casey Ingold1
  • Beyza Cihan3
  • Liz Bridge4
  • Julian Lee Robinson4
  • Gemma Mj Taylor5,6,7
7 affiliations
  1. 1Public Health, East Sussex County Council, East Sussex, UK.
  2. 2Public Health, Surrey County Council, Surrey, UK.
  3. 3Department of Addictions, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.
  4. 4Sussex Health Knowledge and Libraries, Royal Sussex County Hospital, Brighton, UK.
  5. 5Centre for Public Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  6. 6Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  7. 7Department of Psychology, University of Bath, Bath, UK.
Read full textPDFDOICite

Abstract

Objectives

This is a protocol for a Cochrane review (intervention). The objectives are as follows: Primary objective To assess the effects of smoking cessation interventions, compared with no intervention, usual care, placebo, or alternative interventions, on sustained abstinence from smoking in adults with attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), or co-occurring ADHD and ASD. Secondary objectives To assess whether the effects of smoking cessation interventions differ between adults with ADHD, ASD, and co‑occurring ADHD and ASD. To assess whether intervention effects vary according to participant characteristics (e.g. ADHD or ASD symptom profiles, co‑occurring mental health conditions, and alcohol- or substance-use disorders). To assess the safety and acceptability of smoking cessation interventions, including serious and non-serious adverse events and treatment discontinuation.

Related

  1. A comparative evaluation of the efficacy and safety of clonidine and atomoxetine combined with behavioural interventions in children with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder
    Murtadha Abd Noor, Dunya Shnain
    Babcock University Medical JournalPeer-reviewedCC BY-NCFull textGeneral medicineDOAJ
  2. Workplace adjustments equivalent to reasonable accommodations and workplace maladjustment in a general working population, with a focus on high autism spectrum disorder (ASD) and attention deficit/hyperactivity disorder (ADHD) traits
    Tomoko Suzuki, Michiko Nakazato, Toshiyuki Ohtani +1
    Environmental Health and Preventive MedicinePeer-reviewedCC BY 4.0Full textEpidemiology & public healthJ-STAGE
  3. Autism Spectrum Disorder, Attention‐Deficit/Hyperactivity Disorder, Tic Disorder, and Obsessive‐Compulsive Disorder in Individuals With Eating Disorders and Their Siblings: A Nationwide Finnish Cohort Study
    Emma Saure, Pyry N. Sipilä, Susanna Hinkka‐Yli‐Salomäki +3
    The International Journal of Eating DisordersPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthPMC
  4. Anisometropia, Strabismus, and Amblyopia in Children with Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and Their Comorbidity.
    Xiu Nian Chen, Yuzhou Zhang, Xiu Juan Zhang +11
    Ophthalmology sciencePeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
  5. Screen time and attention-deficit/hyperactivity disorder in children: a systematic review and meta-analysis
    Caihong Zhao, Jing Xu, Xirui Wu +1
    Frontiers in pediatricsPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{milne2026smoking,
  title = {{Smoking cessation interventions in adults with attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).}},
  author = {Sarah Milne and Nicola Blake and Emma Jones and Casey Ingold and Beyza Cihan and Liz Bridge and Julian Lee Robinson and Gemma Mj Taylor},
  journal = {The Cochrane database of systematic reviews},
  year = {2026},
  month = oct,
  doi = {10.1002/14651858.cd016400},
  url = {https://europepmc.org/article/MED/42910616},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Smoking cessation interventions in adults with attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
AU  - Sarah Milne
AU  - Nicola Blake
AU  - Emma Jones
AU  - Casey Ingold
AU  - Beyza Cihan
AU  - Liz Bridge
AU  - Julian Lee Robinson
AU  - Gemma Mj Taylor
PY  - 2026
DA  - 2026/10/22
JO  - The Cochrane database of systematic reviews
DO  - 10.1002/14651858.cd016400
UR  - https://europepmc.org/article/MED/42910616
AB  - Objectives  This is a protocol for a Cochrane review (intervention). The objectives are as follows: Primary objective To assess the effects of smoking cessation interventions, compared with no intervention, usual care, placebo, or alternative interventions, on sustained abstinence from smoking in adults with attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), or co-occurring ADHD and ASD. Secondary objectives To assess whether the effects of smoking cessation interventions differ between adults with ADHD, ASD, and co‑occurring ADHD and ASD. To assess whether intervention effects vary according to participant characteristics (e.g. ADHD or ASD symptom profiles, co‑occurring mental health conditions, and alcohol- or substance-use disorders). To assess the safety and acceptability of smoking cessation interventions, including serious and non-serious adverse events and treatment discontinuation.
SN  - 1469-493X
ER  -